T2 Biosystems Tackles Sepsis Testing

The video discusses the challenges faced by the diagnostic industry, particularly related to reimbursement issues, and how T2 is not affected due to its unique approach to sepsis testing. T2 differentiates itself from Theranos by placing instruments in hospitals for rapid testing, which saves costs and improves accuracy. T2 has developed a new diagnostic detection method, backed by 50 patents and FDA approval, and is making a significant impact globally by detecting infections missed by traditional blood culture methods.

What impact is the company seeing in terms of patient detection?

Why is sepsis considered a huge unmet need according to the text?